<DOC>
	<DOCNO>NCT02408926</DOCNO>
	<brief_summary>Young infant vulnerable severe disease even death infect Bordetella pertussis . The current vaccine vaccination program guarantee protection neonate disease . Maternal acquire pertussis-specific antibody show low concentration short persistence newborn create susceptibility gap infection birth first vaccination . A possible strategy protect infant birth pertussis vaccination pregnancy , increase amount passively transfer maternal antibody . However , little known regard effect high titer maternal antibody infant immune response different pertussis vaccine ( whole cell versus acellular ) . Humoral immune response assess infant receive whole cell versus infant receive acellular pertussis vaccine . Functionality antibody also analyze .</brief_summary>
	<brief_title>Vaccine Responses Infants After Acellular Pertussis Vaccination During Pregnancy Thailand</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Willing immunized pertussis contain vaccine pregnancy Intend available followup visit phone call 19 month postpartum Willing infant immunize pertussis contain vaccine 2 , 4 , 6 month 18 month age accord EPI ( Expanded Programme Immunization ) receiving ( randomize ) either acellular pertussis ( aP ) ( study vaccine ) whole cell pertussis ( wP ) vaccine . Consent participation child need married parent single unmarried . At low risk pregnancy relate complication determine investigator second trimester ultrasound significant abnormality . Pregnant subject Multiple pregnancy Serious obstetrical risk Serious underlie medical condition Significant mental illness History febrile illness ( great equal 38Â°C ) within past 72 hour injection Previous severe reaction vaccine Receipt tetanusdiphtheria toxoid immunization within past 1 month Receipt pertussis contain vaccine ( Tdap ) last 5 year Receipt vaccine , blood product ( exclude Rhogam ) within 4 week prior injection 4 week follow injection IVIG ( Intravenous Immunoglobulins ) within 12 week period . One month interval respect another vaccine ( except influenza ) orde evaluate Adverse event follow one vaccine ( fever , local symptom ) Receipt experimental drug pregnancy Anything opinion investigator would prevent woman complete study put woman risk Infants Preterm delivery 37 week gestation Serious underlie medical condition Children suffer primary humoral immune disorder ; suffer primary cellular immune deficiency disorder complete cascade No inform consent one marry parent Severe reaction vaccine Anything opinion investigator would prevent child complete study put child risk</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pertussis</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Humoral immune response</keyword>
	<keyword>Functionality</keyword>
	<keyword>Vaccination</keyword>
</DOC>